Status:
WITHDRAWN
Treat Primary and Metastatic Liver Tumors
Lead Sponsor:
Methodist Health System
Conditions:
Intrahepatic Cholangiocarcinoma
Liver Tumor
Eligibility:
All Genders
18+ years
Brief Summary
The use of Radiospheres in the management of intrahepatic cholangiocarcinoma is largely unknown and not reported in the medical literature. Methodist Dallas Medical Center has a large volume of IR pro...
Detailed Description
A retrospective chart review of patients who have the diagnosis of intrahepatic cholangiocarcinoma. Only patients treated at MDMC are included and data will be obtained from Meditech and Epic. A non-i...
Eligibility Criteria
Inclusion
- Patients with the diagnosis of intrahepatic cholangiocarcinoma from January 2006 until April 2017 at Methodist Dallas Medical Center (MDMC)
- Patients 18 years old or older
Exclusion
- Patients without the diagnosis of intrahepatic cholangiocarcinoma
- Patients under 18 years of age
Key Trial Info
Start Date :
April 26 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05240040
Start Date
April 26 2016
End Date
February 28 2022
Last Update
November 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Methodist Dallas Medical Center
Dallas, Texas, United States, 75203